Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 29, 2002

View Archived Issues

New vaccines reported effective against HPV and HSV infections

Fosamprenavir calcium combined with ritonavir safe and effective in HIV-infected patients

New data on the antiviral efficacy and safety of atazanavir in HIV infection

Teriparatide more effective than alendronate in postmenopausal osteoporosis

Antitumor efficacy of EMD-273063 alone or combined with IL-2

More than 30 years after its introduction, an antibiotic comes back as a novel neuroprotective drug

Enfuvirtide a focus of attention at recent HIV congress

Disappointing preliminary data and negative complete response letter for Replagal

Clinical development program begun for pramipexole in restless legs syndrome

FluINsure vaccine challenge trial commences

Novel opioid analgesics prepared and tested at Euroceltique

Psychotropic agents discovered by Sumitomo scientists

Wyeth presents new oxytocin antagonists with potential as tocolytic agents

New immunosuppressant and antitumor compound isolated at Takeda

BMS researchers present novel inhibitors of HIV reverse transcriptase

Orally active C5a receptor antagonist with potential in inflammatory conditions

Potential new kinase inhibitors for potentiating the effects or radio- and/or chemotherapy

Nabi files BLA for use of Nabi-HB in liver transplant patients

Drug pipeline for schizophrenia

GAM product evaluated in phase I trial for diabetic foot ulcers

Phase I findings for AP-5280 support initiation of phase I/II trial

Ortho Biotech licenses bone morphogenetic protein technology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...